Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12- Week Study to Evaluate the Safety and Efficacy of Oral Difelikefalin in Advanced Chronic Kidney Disease Subjects with Moderate-to-Severe Pruritus and Not on Dialysis with an Up to 52-Week Long-Term Extension

  • Kerr, Peter (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date11/04/23 → 10/04/28